SYNTAX I score is associated with genetically confirmed familial hypercholesterolemia in chinese patients with coronary heart disease

BMC Cardiovasc Disord. 2024 Dec 21;24(1):737. doi: 10.1186/s12872-024-04428-3.

Abstract

Background: Familial hypercholesterolemia (FH) is a genetically inherited disorder caused by monogenic mutations or polygenic deleterious variants. Patients with FH innate with significantly elevated risks for coronary heart disease (CHD). FH prevalence based on genetic testing in Chinese CHD patients is missing. Whether classical index of coronary atherosclerosis severity can be used as indicators of FH needs to be explored. To investigate the FH prevalence in Chinese CHD patients and the association of SYNTAX I score with FH genotype.

Methods: The monogenic and polygenic FH related genes were genotyped in 400 consecutively enrolled CHD patients. The clinical characteristics and SYNTAX I scores were analyzed in a retrospective nested case-control study.

Results: The prevalence of genetically confirmed FH in our CHD cohort was 8.75%. The cLDL-C level, SYNTAX I scores and incidences of triple vessel lesions in FH patients were significantly higher, while cLDL-C and SYNTAX I scores were independent risk factors for FH. Furthermore, cLDL-C levels of polygenic FH were significantly lower than monogenic FH, while their severity of coronary atherosclerosis was comparable.

Conclusions: Our study revealed that the SYNTAX I score was an independent risk factor for FH. Besides, polygenic origin of FH should be taken into consideration for CHD patients suspected of FH.

Keywords: Familial hypercholesterolemia; Monogenic; Polygenic; Prevalence; SYNTAX I score.

MeSH terms

  • Adult
  • Aged
  • Apolipoprotein B-100 / genetics
  • Biomarkers / blood
  • China / epidemiology
  • Coronary Angiography*
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / ethnology
  • Coronary Artery Disease / genetics
  • East Asian People
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Hyperlipoproteinemia Type II* / blood
  • Hyperlipoproteinemia Type II* / diagnosis
  • Hyperlipoproteinemia Type II* / epidemiology
  • Hyperlipoproteinemia Type II* / genetics
  • Male
  • Middle Aged
  • Multifactorial Inheritance
  • Phenotype*
  • Predictive Value of Tests*
  • Prevalence
  • Proprotein Convertase 9 / genetics
  • Receptors, LDL / genetics
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index*

Substances

  • APOB protein, human
  • LDLR protein, human
  • Receptors, LDL
  • Proprotein Convertase 9
  • Biomarkers
  • Apolipoprotein B-100
  • PCSK9 protein, human